Human papillomavirus types from infection to cancer in the 579 anus, according to sex and HIV status: a systematic review and meta-analysis, Lancet Infect Dis, vol.580, pp.198-206, 2018. ,
, , p.582
, , p.583
Human papillomavirus and rising oropharyngeal cancer incidence in 584 the United States, J Clin Oncol Off J Am Soc Clin Oncol, vol.29, pp.4294-301, 2011. ,
, , p.586
Human papillomavirus is a necessary cause of invasive cervical cancer 587 worldwide, J Pathol, vol.189, pp.12-21, 1999. ,
Franceschi 589 S. Carcinogenic human papillomavirus infection, Nat Rev Dis Primer, vol.2, p.16086, 2016. ,
The natural history of cervical HPV infection: unresolved 591 issues, Nat Rev Cancer, vol.7, pp.11-22, 2007. ,
The biology and life-593 cycle of human papillomaviruses, Vaccine, vol.30, pp.55-70, 2012. ,
Ménage à trois: an evolutionary interplay between 595 human papillomavirus, a tumor, and a woman, Trends Microbiol, vol.22, pp.345-53, 2014. ,
Viral and cellular biomarkers in the 597 diagnosis of cervical intraepithelial neoplasia and cancer, BioMed Res Int, p.519619, 2013. ,
, , p.599
Effect of Screening With 600 ,
, Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia 601 at 48 Months: The HPV FOCAL Randomized Clinical Trial, JAMA, vol.320, pp.43-52, 2018.
, , p.603
Comparing the performance of six human papillomavirus tests in a screening 604 population, Br J Cancer, vol.108, pp.908-921, 2013. ,
Performance of mRNA-and DNA-based 606 high-risk human papillomavirus assays in detection of high-grade cervical lesions, Acta Obstet, p.607 ,
, , vol.96, pp.61-69, 2017.
, , p.609
Aptima HPV Assay versus Hybrid Capture® 2 HPV 610 test for primary cervical cancer screening in the HPV FOCAL trial, J Clin Virol Off Publ Pan Am Soc, p.611 ,
, Clin Virol, vol.87, pp.23-32, 2017.
, Aptima Human, p.613
, Papillomavirus E6/E7 mRNA Test Results Strongly Associated With Risk for High-Grade Cervical 614
, Lesions in Follow-Up Biopsies, J Low Genit Tract Dis, vol.22, 2018.
Concordant testing results between various human 616 papillomavirus assays in primary cervical cancer screening: systematic review, Clin Microbiol, p.617 ,
, Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.24, pp.29-36, 2018.
Not all HPV nucleic acid tests are equal: only those 619 calibrated to detect high grade lesions matter for cervical screening, Clin Microbiol Infect Off, vol.620 ,
, Publ Eur Soc Clin Microbiol Infect Dis, vol.24, pp.436-443, 2018.
Not all HPV nucleic acid tests are equal: only those 622 calibrated to detect high grade lesions matter for cervical screening: Response to "Concordant 623 testing results between various human papillomavirus assays in primary cervical cancer 624 screening: systematic review" by de Thurah, Bonde, Uyen, Lam and Rebolj, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.24, pp.438-447, 2017. ,
, , p.627
Screening assay using the VALGENT framework, J Clin Virol Off Publ Pan Am, vol.628 ,
, Soc Clin Virol, vol.81, pp.6-11, 2016.
, , p.630
Evolution and Taxonomic Classification of Alphapapillomavirus 7 Complete 631 ,
, Genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70, vol.8, p.72565, 2013.
, , p.633
Geneious Basic: an 634 integrated and extendable desktop software platform for the organization and analysis of 635 sequence data, Bioinforma Oxf Engl, vol.28, pp.1647-1656, 2012. ,
Papillomavirus genome structure, expression, and post-transcriptional 637 regulation, Front Biosci J Virtual Libr, vol.11, pp.2286-302, 2006. ,
Construction of a full transcription map of 639 human papillomavirus type 18 during productive viral infection, J Virol, vol.85, p.26, 2011. ,
Characterization 641 of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions ,
, Oncogene, vol.21, pp.419-445, 2002.
The landscape of viral 644 expression and host gene fusion and adaptation in human cancer, Nat Commun, vol.4, p.2513, 2013. ,
MYC activation associated 646 with the integration of HPV DNA at the MYC locus in genital tumors, Oncogene, vol.25, p.93, 2006. ,
Multiple-integrations of HPV16 649 genome and altered transcription of viral oncogenes and cellular genes are associated with the 650 development of cervical cancer, PloS One, vol.9, p.97588, 2014. ,
The 652 majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences 653 of known or predicted genes, Cancer Res, vol.68, pp.2514-2536, 2008. ,
655 STAR: ultrafast universal RNA-seq aligner, Bioinformatics, vol.29, pp.15-21, 2013. ,
Regularization Paths for Generalized Linear Models via 657 ,
, Coordinate Descent. J Stat Softw, vol.33, pp.1-22, 2010.
, , p.659
, PapilloCheck test, a new commercial DNA chip for detection and genotyping of human 660 papillomavirus, J Virol Methods, vol.156, pp.77-83, 2009.
, , p.662
Comparison of the performance of different HPV genotyping methods for 663 detecting genital HPV types, J Med Virol, vol.80, pp.1264-74, 2008. ,
, , vol.665
Management of 666 (average values), (B) Viral transcripts E6 & E7 (average values). The relative abundance (y-axis, log 734 scale) is calculated in comparison to the higher expression value of the dataset, p.735 ,
, JPEG, vol.736, issue.2, p.2233
, Supplemental Figure 2: Evaluation of transport medium for RNA conservation: RNA integrity at D0, vol.2, p.738
Bioanalyzer gel-like visualization of RNA profiles, showing 18S and 28S rRNA 739 populations (two distinct bands) as a marker of RNA integrity ,
, Supplemental Figure 3: Positive Predictive Value (PPV) of HPV RNA-Seq vs histology (in blue) and of 741 cytology vs histology (in red) function of the prevalence of HSIL in the population (P HSIL), p.743